Stay updated on CC-97540 in Severe SLE Clinical Trial
Sign up to get notified when there's something new on the CC-97540 in Severe SLE Clinical Trial page.
Latest updates to the CC-97540 in Severe SLE Clinical Trial page
- Check3 days agoChange DetectedNo significant additions or deletions were detected on the Study Details page for NCT05869955; core information such as the study title, conditions, interventions, and locations remains unchanged.SummaryDifference0.1%
- Check10 days agoChange DetectedThe update adds an expanded list of study locations across US and international sites and updates eligibility criteria language for SLE, IIM, SSc, and RA cohorts, while removing several previous location blocks.SummaryDifference2%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNo significant changes detected between the old and new screenshots; observed differences are minor UI/layout updates and non-substantive wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check31 days agoChange DetectedAdded an estimated Last Update Posted timestamp and a new Revision label (v3.3.2) to the study page. The previous Last Update Posted entry and the older revision label (v3.2.0) were removed.SummaryDifference0.1%
- Check38 days agoChange DetectedNew recruitment site Local Institution - 0028 was added. The inclusion criteria were updated to require inadequate response to ≥3 immunosuppressive therapies (IST); the last update posted is 2025-11.SummaryDifference0.6%
- Check46 days agoChange DetectedNo significant additions or deletions were detected; the page content and structure appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
Stay in the know with updates to CC-97540 in Severe SLE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-97540 in Severe SLE Clinical Trial page.